Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
about
The Possible Future Roles for iPSC-Derived Therapy for Autoimmune DiseasesThe biology and mechanism of action of suppressor of cytokine signaling 3Immunobiology of mesenchymal stem cellsRemyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple SclerosisHighlights of the advances in basic immunology in 2011.The stem cell secretome and its role in brain repair.How stem cells speak with host immune cells in inflammatory brain diseasesNeuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease.Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism.Moving stem cells to the clinic: potential and limitations for brain repairRegulation of astrocyte activation by glycolipids drives chronic CNS inflammation.Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice.The Active Form of Vitamin D Transcriptionally Represses Smad7 Signaling and Activates Extracellular Signal-regulated Kinase (ERK) to Inhibit the Differentiation of a Inflammatory T Helper Cell Subset and Suppress Experimental Autoimmune EncephalomySuppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitorImmune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.SOCS, Inflammation, and Autoimmunity.Gene set enrichment analysis identifies LIF as a negative regulator of human Th2 cell differentiationTIR Domain-Containing Adapter-Inducing Beta Interferon (TRIF) Mediates Immunological Memory against Bacterial Pathogens.How mesenchymal stem cells interact with tissue immune responses.Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection?New perspectives of tissue remodelling with neural stem and progenitor cell-based therapiesExogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.Concise review: mesenchymal stem cells and translational medicine: emerging issues.RNA in blood is altered prior to hemorrhagic transformation in ischemic strokeSOCS3, a Major Regulator of Infection and Inflammation.Oncostatin M Suppresses Activation of IL-17/Th17 via SOCS3 Regulation in CD4+ T Cells.Therapeutic effects of human adipose tissue-derived stem cell (hADSC) transplantation on experimental autoimmune encephalomyelitis (EAE) mice.Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.Mesenchymal stem cells: a new trend for cell therapy.Cross-talk between neural stem cells and immune cells: the key to better brain repair?The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.Value added: neural progenitor cells suppress inflammation and autoimmunityImmunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.Improving the neuronal differentiation efficiency of umbilical cord blood-derived mesenchymal stem cells cultivated under appropriate conditions.Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.A shRNA functional screen reveals Nme6 and Nme7 are crucial for embryonic stem cell renewal.Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous SystemMultiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice Model.
P2860
Q26799472-67245818-6EC7-436C-BB10-44C6E44600B1Q27003933-2E5409EE-587D-4638-8BAA-229DC3B6495EQ27004487-FAC58194-2D0D-4439-95CA-5EE06D42FF91Q27339236-90CD18A9-D44B-4F7E-B909-C5FB87871504Q33577368-0DD47F4D-A453-46E8-AF6F-EC0991CEF437Q33771698-A02FB68F-E9FF-415D-9727-B6977164BB37Q33776557-852F4456-9DD9-4A31-B1EF-69F6AF67A372Q34172960-A470C8D3-CF3F-4639-9AA2-06EE0B2AA55AQ34241152-B8260FD2-D24F-4153-BCB8-9608C9D20B53Q34450780-331A52F6-4809-4ED6-98B2-CB42F76E1014Q34470920-94772870-93B8-494B-B245-7D55E733C566Q34632490-FF365D08-62E7-472C-8F36-7D481C8F02DBQ35187144-1486A5D5-1F80-4AA0-98BB-3579F91B3A02Q35583149-E775A54F-10C2-4CEC-B362-D64476F62F31Q35718387-EEBDF6B2-5F42-4FAE-82FD-2CF7A00044B7Q35794350-8B4EC468-1A40-445F-9134-C4759B03FFA3Q35927538-B67A6158-955F-452A-AF7C-147E12A4ADFDQ36036457-F4ADBACB-9156-49DD-BE17-24777FB95AEAQ36137937-D78417A3-8032-451D-A741-1D9C4FAFF89DQ36141205-25060E3F-575F-48B1-AEBB-3AD76F7065C7Q36330492-710690C9-0C2E-44B2-8979-6C10DC09069BQ36547098-4DA886B2-0FEF-4CA4-99F6-8E5FD12EB05AQ36563408-E8B41CAA-4580-4071-AD6F-DE39AC4BCFD5Q36580701-D491A1D2-EB97-43AA-83F5-ACAA31791DDAQ37056276-535F0719-CAA4-4612-8B9B-BC47371A41E4Q37118070-F0C30D36-A932-4A95-9F76-3BD26D8FF369Q37592325-464B060B-41DF-4CF4-856E-374AF3F06D84Q37625477-5D50F13C-54BA-4B52-879D-B506D88E0D77Q37642800-D3099EB6-D409-49B8-84F1-C80B71E3768DQ37670027-F4956AA6-6167-46A6-B01C-31949E4008D4Q37729093-FEC67280-C4EA-403D-BAD7-F8263B29755BQ38029969-94F62EE3-7C3B-40E6-80DA-E4510A0EFFEFQ38083604-634F887F-9069-4F9F-B091-622460EBE181Q38526117-E386BF51-87A1-4EF8-BA4C-D35DCC53DB9DQ38534740-485D5288-30D2-42C3-879B-46BFFB05F8AEQ38600754-D8AF8D9D-2A1B-48A7-AFC0-8D9DADFA8333Q39279957-42B08312-3408-43C4-9A43-162712F53FA4Q39296177-9C37E04C-ACB6-4F0E-A9B0-81B0DE9646D3Q39335873-CAD2ED43-66A4-41FB-9163-37DD8782DC35Q40072578-BAB14B18-E9F2-4260-9B4C-9261E05E8ECE
P2860
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Leukemia inhibitory factor inh ...... therapy in autoimmune disease.
@en
Leukemia inhibitory factor inh ...... therapy in autoimmune disease.
@nl
type
label
Leukemia inhibitory factor inh ...... therapy in autoimmune disease.
@en
Leukemia inhibitory factor inh ...... therapy in autoimmune disease.
@nl
prefLabel
Leukemia inhibitory factor inh ...... therapy in autoimmune disease.
@en
Leukemia inhibitory factor inh ...... therapy in autoimmune disease.
@nl
P2093
P1433
P1476
Leukemia inhibitory factor inh ...... therapy in autoimmune disease.
@en
P2093
Ailian Liu
Fenglan Wu
Jingwu Z Zhang
Stewart Leung
Yiqing Yang
Yufang Shi
P304
P356
10.1016/J.IMMUNI.2011.06.011
P407
P577
2011-08-11T00:00:00Z